ACTISITE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Actisite, and when can generic versions of Actisite launch?
Actisite is a drug marketed by Schiff And Co and is included in one NDA.
The generic ingredient in ACTISITE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Actisite
A generic version of ACTISITE was approved as tetracycline hydrochloride by WATSON LABS on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACTISITE?
- What are the global sales for ACTISITE?
- What is Average Wholesale Price for ACTISITE?
Summary for ACTISITE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| Patent Applications: | 4,504 |
| DailyMed Link: | ACTISITE at DailyMed |
US Patents and Regulatory Information for ACTISITE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schiff And Co | ACTISITE | tetracycline hydrochloride | FIBER, EXTENDED RELEASE;PERIODONTAL | 050653-001 | Mar 25, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
